There is a particular kind of corporate behavior that reveals more about a company's insecurities than its strengths. Filing a 111-page lawsuit against a team of twenty people, in the same week you announce a $575 million funding round, is one of those moments.
Whoop, the Boston-based fitness wearable maker valued at $10.1 billion, filed suit on March 17, 2026, against Finerpoint, Inc. (the company behind the health analytics app Bevel) in the U.S. District Court for the District of Delaware. The case (1:2026cv00289) alleges trade dress infringement under the Lanham Act, along with copyright and patent infringement tied to four patents covering proprietary biometric data. Whoop is seeking injunctive relief, monetary damages, and attorney fees. For a company that just closed one of the largest funding rounds in wearables history, the timing landed like a statement.
Bevel CEO and co-founder Grey Nguyen didn't stay quiet. In a video posted to X, he framed it bluntly: "A $10B company with 800+ employees is scared of us, a 20-person team making health tracking accessible to all. Rather than focusing on product and innovation, Whoop has decided to use its newly raised capital on lawfare."
@WHOOP just filed a lawsuit against us.
— Grey (@greyngyen) April 3, 2026
A $10B company with 800+ employees is scared of us, a 20-person team making health tracking accessible to all.
Rather than focusing on product and innovation, Whoop has decided to use its newly raised capital on lawfare.
In this video, I… pic.twitter.com/gpi6AUpc40
It's a pointed accusation. But the legal questions underneath it are genuinely complicated.
What Bevel Actually Does
Understanding this lawsuit requires understanding what Bevel is, and what it isn't. Bevel does not manufacture hardware. It has no sensor, no strap, no subscription tier charging you every month just to see your own data. It is a smartphone application that pulls biometric data from devices you already own, including Garmin watches and Apple-connected hardware, and presents that data through a recovery-and-readiness framework that will feel familiar to anyone who has spent time in the Whoop ecosystem.
That familiarity is precisely the problem, according to Whoop. The interface prioritizes recovery scores, sleep quality, and daily strain: surfaced front and center, in a visual language that echoes Whoop's own app. For users who left Whoop's hardware ecosystem but liked the way Whoop framed their health data, Bevel became a natural landing spot. For a company approaching an IPO (and Whoop's recent fundraise has IPO speculation in overdrive), that is not a dynamic you want gaining momentum.
The lawsuit's trade dress claims center on what Whoop calls the look and feel of its application: the specific way health metrics are visualized, the recovery-first hierarchy of information, the overall aesthetic experience of navigating your data. Trade dress protection is notoriously difficult to establish for software interfaces: it requires showing that the design elements are non-functional, distinctive enough to serve as a brand identifier, and that consumers are genuinely likely to be confused about affiliation. Whoop's 111-page complaint suggests they believe they can clear all three bars.
The patent claims go further. According to court filings, Whoop is asserting four patents related to proprietary biometric data processing — the kind of underlying algorithmic logic that converts raw sensor input into the recovery scores and strain calculations that define the Whoop experience. This is where the lawsuit gets technically thorny. Bevel does not generate its own biometric readings; it interprets data collected by third-party hardware. Whether that interpretation, applied to data pulled through Apple Health or Garmin Connect, constitutes infringement of patents on biometric data processing is a question that will ultimately require a judge to sort out.
The Collaboration That Wasn't
What makes the lawsuit harder to take at face value is the context Nguyen provided around how Whoop and Bevel's relationship actually began. According to Nguyen, two Whoop employees reached out to Bevel in June 2024, nearly two years before the complaint was filed, to explore a potential collaboration. One employee described Bevel's work in the "athletic performance and wellness space" as "inspiring and thought-provoking" and floated the idea that there could be "opportunity for valuable collaboration between our companies."
That outreach did not produce a partnership. What it apparently produced, eventually, was a lawsuit from the party who initiated contact. Whoop has not publicly addressed this sequence of events. But if accurate, it reframes the legal filing considerably. Companies do not typically reach out to express admiration for the work of entities they consider infringers. They send cease-and-desist letters.
Whoop's Pattern of Aggressive IP Enforcement
To be fair to Whoop, this lawsuit did not emerge from nowhere. The company has been building out an IP enforcement posture for some time, and its record suggests it takes this seriously. In September 2025, Whoop sued Chinese manufacturer Shenzhen Lexqi over a fitness tracker that was, by most accounts, a near-identical copy of Whoop's screenless hardware design. A federal judge in Massachusetts granted Whoop a preliminary injunction in February 2026, ordering Lexqi to halt U.S. sales. The court found Whoop's trade dress was non-functional, distinctive, and that consumers were genuinely confused: one Amazon reviewer referred to the Lexqi device as a "Whoop band." That case had genuine merit.
Whoop also has an active suit against Polar, the Finnish fitness brand, over its Loop product, which Whoop claims infringes on its hardware design and patents. And with an IPO on the horizon, the legal clean-up makes strategic sense: investors and underwriters want to see that a company's IP position is defensible, not leaky.
The Bevel case, though, is different from Lexqi in a way that matters. Lexqi was selling hardware that looked nearly identical to Whoop's physical product. Bevel is a software application that processes data Whoop does not collect. The comparison shifts from "did you copy our product" to "did you copy the way we present information about a product": a much harder legal and philosophical case to make, and one with implications that extend well beyond these two companies.
The Broader Question Nobody Wants to Answer
At some level, Whoop's core claim against Bevel is that recovery-and-readiness scoring, presented in a specific visual hierarchy, belongs to them. If a court agrees (and the bar for that finding is not trivial), it raises uncomfortable questions about how much of a user experience a company can own. Recovery scores, sleep staging, HRV analysis, and strain calculations are not unique inventions. They are analytical frameworks applied across the health and fitness industry. What Whoop arguably owns is the specific way it assembles and presents those frameworks. The question is whether that ownership extends to anyone who builds a UI that reminds users of Whoop's approach.
As a Bevel user, you have an obvious stake in this. Bevel's appeal is precisely that it delivers a Whoop-adjacent analytical framework to people using devices they already own: an Apple Watch, a Garmin, whatever is already on your wrist. It makes health tracking less expensive and less proprietary. If Whoop succeeds in shutting that down, or forces a redesign significant enough to gut the experience, users lose a product that fills a genuine gap in the market.
Whether Whoop's IP claims are ultimately valid is a question for the Delaware court system, and patent and trade dress litigation routinely takes years to resolve. But the business logic behind this filing is visible from a distance. Bevel recently opened much of its app for free, accelerating its user growth at precisely the moment Whoop is trying to consolidate its market position ahead of a public offering. A 20-person team making Whoop's analytical approach accessible to non-Whoop users, without the hardware lock-in or the subscription, is an existential nuisance if you are trying to argue to IPO investors that your ecosystem is defensible.
That is not an accusation of wrongdoing. Companies protect their intellectual property. But there is a difference between protecting genuine innovation and using a litigation budget to suppress a competitor that built something better for a user base you underserved. The answer to which category this falls into may arrive before a judge does.
Subscribe to our newsletter to get the latest Apple updates and news
Member discussion